| Ind-Swift Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532305 |
NSE Symbol : INDSWFTLAB |
P/E(TTM) : 48.12 |
|
ISIN Demat : INE915B01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 7.68 |
|
Book Value(₹) : 157.53 |
Market Cap(₹Cr) : 3,213.66 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 186.08 | 172.70 | 153.17 | 150.44 | 147.99 | 149.52 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 186.08 | 172.70 | 153.17 | 150.44 | 147.99 | 149.52 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 7.63 | 2.21 | 23.89 | 17.86 | 14.58 | 215.52 |
| Total Income | 193.71 | 174.91 | 177.06 | 168.30 | 162.58 | 365.04 |
| Total Expenditure | 152.99 | 157.55 | 149.94 | 148.25 | 144.92 | 158.21 |
| PBIDT | 40.72 | 17.36 | 27.12 | 20.05 | 17.65 | 206.83 |
| Interest | 0.71 | -2.44 | 0.67 | 2.01 | 1.15 | -26.76 |
| PBDT | 40.01 | 19.80 | 26.45 | 18.03 | 16.50 | 233.58 |
| Depreciation | 7.58 | 8.08 | 8.84 | 6.98 | 6.68 | 7.44 |
| Tax | 7.98 | 2.18 | 6.87 | 2.30 | 1.71 | 11.88 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | -5.40 | 0.00 | 0.00 | 0.00 | -3.83 |
| Reported Profit After Tax | 24.44 | 14.94 | 10.74 | 8.76 | 8.12 | 218.09 |
| Extra-ordinary Items | -0.18 | -4.19 | -3.57 | 0.00 | 0.00 | 204.54 |
| Adjusted Profit After Extra-ordinary item | 24.62 | 19.13 | 14.31 | 8.76 | 8.12 | 13.55 |
| EPS (Unit Curr.) | 2.81 | 1.79 | 1.32 | 1.10 | 1.18 | 32.34 |
| EPS (Adj) (Unit Curr.) | 2.81 | 1.79 | 1.32 | 1.10 | 1.18 | 32.34 |
| Calculated EPS (Unit Curr.) | 2.81 | 1.72 | 1.32 | 1.07 | 1.18 | 31.72 |
| Calculated EPS (Adj) (Unit Curr.) | 2.81 | 1.72 | 1.32 | 1.07 | 1.18 | 31.72 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.24 | 6.88 | 5.26 | 4.29 | 4.72 | 126.90 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.24 | 6.88 | 5.26 | 4.29 | 4.72 | 126.90 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 86.96 | 86.84 | 81.61 | 81.61 | 68.74 | 68.74 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.88 | 10.05 | 17.71 | 13.33 | 11.93 | 138.33 |
| PBDTM(%) | 21.50 | 11.46 | 17.27 | 11.98 | 11.15 | 156.22 |
| PATM(%) | 13.13 | 8.65 | 7.01 | 5.82 | 5.49 | 145.86 |
